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INTRACORONARY STENTING TO PREVENT RESTENOSIS: 
;RENtEiINY RESULTS OF A MULTIcENTER STUDY 
Z STENT SUGGEST BENEFIT 
IN SELECTED HIGH RISK 3’ATIENTS. 
SG Ellis MD FACC, M siivage MD FACC, D Bairn MD FACC, 
J Hirshfeld MD FACC, M Cleman MD FACC, P Teirstein MD 
ECZq$l MD FACC. University of Mchigan Hospital, 
, - 
Coronary stenting has been proposed to prevent restenosis 
(‘ES) following PKA. Of 226 pk felt to be at moderate or 
high risk for RES and stented through July 1989, 87 (93 sites) 
have had angiographic restudy at 2-6 months per protocoI or 
because of recurrent symptoms (96% of eligible for follow-up). 
Of pk with follow-up, 62% had prior RES, 33% had left anterior 
descending (LAD) PTCA, 14% had chronic total occlusion K'I'OI 
PKA, 1.420.9 stenk were placed per stenosis, and mean time 
to follow-up was 5.2#.3 months. RES, defined as 250% stenosis 
(calipers), was seen m 33/93 = 35% of sites, but ik jncidence 
was highly dependent in multivariate analysis on c stenk/ 
stenosis placed Q~O.001) and the final stent site diameter ~3.2 
mm @=0.02). 
Restenosis Results 
ultiple 
Diameter 1 Stenl 
~3.2 mm 7/43 = 16% 
Ov$;zJping Stenk 
= 53% 
~3.2 mm 7124 = 29% ll/ll = 100% 
High risk pk (LAD, CTO) receiving 1 stent had RES in S/25 
= 2096, no worse than moderate risk pk 9/42 = 21% (p=NS). 
Further, 30% of RES had stenosis ~60% and no ischemia on 
stress testing. Thus, when these restits are compared to 
historical controls, intracoronary stenting appears promising to 
reduce the risk of restenosis in selected high risk pk. 
THE TEMPORARY STENT CATHETER : 
A NON OPERATIVE TREATMENT FOR ACUTE 
OCCLUSION DURING CORONARY ANGIOPLASTY 
tier, M.D., Gerard L. 
Lyon, France 
SurgicaI standby can not always avoid myocardial infarction 
in case of acute vessel closure during coronary angioplasty 
(PICA). We studied the effectiveness of a temporary stent 
cathrter (‘l”Sc) to aear safely an acute occlusion during P’K!A. 
The TSC is a 4F catheter with a stainless steel mesh at the 
distal tip. The TSC is positionned across the occlusion, 
deployed during 30 to 90 mn and then removed. Exuerimencal 
midi& in dogs iifi anterior descending coronary arte&& (&i57 
have proved the safety of the TSC in normals LAD and the 
tfficacy to nstOn patency in experimental dissected LAD. 
The TSC was used in 3 patients with acute occlusion 
during FTCA : 1 of a proximal LAD, and 2 of a proximal large 
dominant right coronary artery (RCA). 
&&s : The TX nstorcd immediately antegrade blood flow 
with chest pain relieved and with normalization of ST segment 
elevation. For the fast patient (LAD), the TSC was used as a 
“bail out" device before proceeding to bypass surgery (CABG). 
In the 2 remains patients (RCA), the TSC was removed after 30 
mn. Fxcellent angiographic result avoided emergency CABG. 
Anpographic control at 14 days showed in each case a patent 
RCA tith perfect healing of the FTCA - associated dissection. 
Conclusion : This retrievable new device is effective to aat 
acute occlusion during PTC4 . Funher investigations are needed 
to evaluate if the TSC is able to “bypass” surgical standby. 
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A new radiopaque highly flexible (zig-tag 
balloon-expandable tantalum dent (Cordis Corp 
hatters) 
tested in canine coronary arteries. Out of a 
stents (2.5-3.5 nun wide x 1.6-2.2 cm long). 35 
easily ind successfully deployed percutaneously through a 
auide catheter to oroximal (3 
{31X) locations in'the left‘ant&ior 
heparin (5,000 units ) during the procedure and treated 
with aspirin alone 
following traumatic i
Mean neointimal thickness within the stented area 
was 500~98 microns in 3 dogs sacrificed at 2223 days and 
400$170 microns in 7 doas sacrificed at 2201t35 
Medial compression was iioted only in areas 
beneath stent struts. Follow-up arteriography performed 
on surviving stents at 
months (n=l5) and 1 yea 
eek (n=26), 1 month (n=22), 6 
patency in all animals 
n=4) showed persistent wide 
h mean SARIS of 1,3:1, 1.3:1, 
1.3:1 and 1.1:1 respec 
This tantalum stent exhibits ease of place 
early neointimal formation, low thrombogenicity 
long-term anticoagulant therapy, and patency up 
in this model. Intimal hyperplasi 
appears to remain stable and there re no instances of 
early or late perforation or aneurysm formation. 
ANGIOGWHJC PATENCY OF A COILSTENT 
Stephen 
e C. Ross 
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F.A.C.C., Jeffrey M. Isner, M.DI, F.A.kC.. Ochsner &ledicai 
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We investigated the angiographic patency rate of a new balloon- 
expandable tantalum coil stem implanted in peripheral and coronary 
arteries in atherogenic miniature swine fed a high-cholesterol diet. The 
stems were constructed of tantalum wire, 0.005” in diameter, and 
crimped tightly over” commercially available coronary angioplasty 
balloon catheters, 2.0 to 4.0 mm in diameter. The stems were placed in 
19 coronary arteries and 32 iliac arteries in a total of 25 miniature swine 
through an 8 Fr coronary angioplasty guiding catheter. Immediately 
prior lo stem implantation the animals were systemically heparinized, 
250 cc of low molecular weight dexuan were infused intravenously, and 
intracoronary nitroglycerin was given. No long-term anticoagulation 
was administered. The number of stents studied at each interval was as 
follows: 
led 
e imulanted stems without evifenace of irAxiluminal 
throm6us or -k&ration 6f the stem. A major advantage of this stem is 
the excellent longitudinal flexibility inherent in the coil design which 
improves the trackability of the non-deployed stent in reaching the target 
lesion, and allows the expanded stent lo conform to the natural contour 
of tortuous arteries. These tantalum wire devices were also notable for 
iheir excellent fluoroscopic visibility. This study demonstrated this 
stem@ ease of delivgr and excellent angiographic parzncy rate for up to 
8 months in both peripheral and coronary arteries without the 
development of stenotic lesions in this atherogenic model. 
